• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 1.44
( 0.00%)
Global Indices
Nasdaq
52,663.96 134.69
(0.26%)
Dow Jones
7,591.19 26.60
(0.35%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

RBL Bank Ltd
Industry :  Banks - Private Sector
BSE Code
ISIN Demat
Book Value()
540065
INE976G01028
274.1016647
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RBLBANK
70.23
57745.73
EPS(TTM)
Face Value()
Div & Yield %
5.31
10
0.11
 

gallantt ispat ltd
Dr Reddy’s Labs receives seven USFDA observations for Hyderabad facility
Jun 26,2026
At the conclusion of the inspection, USFDA issued a Form-483 with seven observations. The company said it will address within the stipulated timeline.

Previously, the USFDA had conducted a Pre-Approval Inspection (PAI) at the same Hyderabad facility between 4 September and 12 September 2025, following which it had issued five observations.

Hyderabad-based Dr. Reddy’s Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

The company reported a 86.14% decline in consolidated net profit to Rs 220.9 crore on 11.51% drop in revenue from operations to Rs 7,546.4 crore in Q4 FY26 over Q4 FY25.

The counter advanced 1.63% to settle at Rs 1,350 on Thursday, 25th June 2026. The NSE and BSE remain closed today on account of Muharram.